Home/CellCentric/Jason Dinges
JD

Jason Dinges

Chairman, Investor Director & Board Member

CellCentric

Therapeutic Areas

CellCentric Pipeline

DrugIndicationPhase
inobrodib (CCS1477)Multiple MyelomaPhase 1/2
inobrodib + Pd (InoPd)Relapsed/Refractory Multiple MyelomaPhase 1/2